3.Pulmonary Risk Factors.
Korean Journal of Anesthesiology 1989;22(5):607-614
No abstract available.
Risk Factors*
5.Role of Transcription Factors in Bone and Vascular Mineralization.
Journal of Korean Society of Endocrinology 2005;20(6):589-596
No Abstract available.
Transcription Factors*
6.One wing of nation's health: reducing health inequalities.
Journal of the Korean Medical Association 2013;56(3):165-166
No abstract available.
Socioeconomic Factors
7.Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?.
Journal of Gynecologic Oncology 2013;24(1):1-2
No abstract available.
Risk Factors
8.Clinical studies on risk factors of preterm delivery.
Ey Seob SIM ; Tae Hyung KIM ; Myung Jin KIM ; Yong Bong KIM ; Sung Kwan PARK
Korean Journal of Perinatology 1993;4(4):504-511
No abstract available.
Risk Factors*
9.Endoscopic Treatment with Band Ligation and Electrocoagulation for Non-Variceal, Non-Ulcer Upper Gastrointestinal Bleeding.
Hwa Min KIM ; Yang Suh KU ; Moon Gi CHUNG ; Young Nam KIM ; Do Yoon LIM ; Kwang An KWON ; Dong Kyun PARK ; Sun Suk KIM ; Yeon Suk KIM ; So Young KWON ; Yu Kyung KIM ; Duck Joo CHOI ; Ju Hyun KIM
Korean Journal of Gastrointestinal Endoscopy 2006;33(2):69-76
BACKGROUND/AIMS: This study compared the therapeutic efficacy of endoscopic band ligation (EBL) with that of electrocoagulation for treating non-variceal, non-ulcer (NVNU) upper gastrointestinal (UGI) bleeding. METHODS: This study included 89 patients who underwent EBL and 56 patients in whom monopolar electrocoagulation was performed for NVNU UGI bleeding. The lesions treated were Mallory-Weiss tear in 91 patients, Dieulafoy's lesion in 42 patients and angiodysplasia in 12 patients. RESULTS: The initial hemostatic rate was 97% in the EBL group and 91% in the electrocoagulation group, but this was not statistically different. Rebleeding occurred in 5 of 89 patients (5.6%) in the EBL group and in 8 of 56 patients (14.3%) in the electrocoagulation group (p=0.07). Thrombocytopenia or prothrombin time prolongation was confirmed to be a significant risk factor for rebleeding. The rebleeding rate in the high risk group was significantly lower than in the EBL group (9% vs. 30%, respectively, p=0.03). The median procedure time was significantly shorter in the EBL group compared with that in the electrocoagulation group (median 5.6 minutes vs. 8.3 minutes, respectively, p=0.04). CONCLUSIONS: EBL and electrocoagulation are both effective for treating NVNU UGI bleeding, and EBL is especially safe and effective for the cases with a high risk for rebleeding.
Risk Factors
10.Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome.
Journal of Korean Society of Pediatric Endocrinology 2010;15(2):77-84
Non-alcoholic fatty liver disease (NAFLD), the most common liver disease, represents a spectrum of disease including steatohepatitis, fibrosis, and irreversible cirrhosis. Although a "benign" condition, NAFLD is a risk factor eventually leading to fibrosis and to non-alcoholic steatohepatitis (NASH). A number of evidences support an association between NAFLD/NASH and metabolic syndrome. The pathogenesis of NAFLD/NASH and metabolic syndrome seems to have common pathophysiological mechanisms, with focus on insulin resistance as a key factor. This review discusses the new aspects of NAFLD/NASH pathogenesis, and anticipate that such knowledge will eventually serve to the deveolpment of novel treatment strategies for this disease.
Risk Factors
Result Analysis
Print
Save
E-mail